All variants in the LDLR gene

Information The variants shown are described using the NM_000527.4 transcript reference sequence.

4 entries on 1 page. Showing entries 1 - 4.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Enzyme activity     

Predict-BioInf     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     
-?/-? 4 c.344G>A r.(?) p.(Arg115His) LDL-receptor class A3 64% LDLR on cell surface, 64% LDL binding and internalization in transfected COS cells {PMID12837857:Chang et al 2003 J Lipid Res 44 1850}. PolyphenII: benign, 0.157, HumVar benign, 0.128; SIFT: Tolerated, SIFT2 Not tolerated; MutationTaster: disease causing; conservation: 0.54 (Ch, Rh, D, P, B, M, Ra, H, Rb, Ck, Z) ACGS likely pathogenic g.11215926G>A g.11105250G>A R94H; FH Fukuoka - LDLR_000052 predicted retained in ER; Reported as a Htz in one clinically Htz FH patient; Functional analysis reveals retention in ER; Also reported in ZA PubMed: Khoo 2000 - rs201102461 Germline - 0.0001838 ExAC, May 2015 - - - Sarah Leigh
-?/-? 4 c.344G>A r.(?) p.(Arg115His) LDL-receptor class A3 64% LDLR on cell surface, 64% LDL binding and internalization in transfected COS cells {PMID12837857:Chang et al 2003 J Lipid Res 44 1850}. PolyphenII: benign, 0.157, HumVar benign, 0.128; SIFT: Tolerated, SIFT2 Not tolerated; MutationTaster: disease causing; conservation: 0.54 (Ch, Rh, D, P, B, M, Ra, H, Rb, Ck, Z) ACGS likely pathogenic g.11215926G>A g.11105250G>A R94H; FH Fukuoka - LDLR_000052 predicted retained in ER; Functional analysis reveals retention in ER. PubMed: Yu 2002 - rs201102461 Germline - 0.0001838 ExAC, May 2015 - - - Sarah Leigh
-?/-? 4 c.344G>A r.(?) p.(Arg115His) LDL-receptor class A3 64% LDLR on cell surface, 64% LDL binding and internalization in transfected COS cells {PMID12837857:Chang et al 2003 J Lipid Res 44 1850}. PolyphenII: benign, 0.157, HumVar benign, 0.128; SIFT: Tolerated, SIFT2 Not tolerated; MutationTaster: disease causing; conservation: 0.54 (Ch, Rh, D, P, B, M, Ra, H, Rb, Ck, Z) ACGS likely pathogenic g.11215926G>A g.11105250G>A R94H; FH Fukuoka - LDLR_000052 predicted retained in ER; Functional analysis reveals retention in ER. PubMed: Kim 2004 - rs201102461 Germline - 0.0001838 ExAC, May 2015 - - - Sarah Leigh
-?/+? 4 c.344G>A r.(?) p.(Arg115His) LDL-receptor class A3 64% LDLR on cell surface, 64% LDL binding and internalization in transfected COS cells {PMID12837857:Chang et al 2003 J Lipid Res 44 1850}. PolyphenII: benign, 0.157, HumVar benign, 0.128; SIFT: Tolerated, SIFT2 Not tolerated; MutationTaster: disease causing; conservation: 0.54 (Ch, Rh, Dg, P, B, M, Ra, H, Rb, Ck, Z) ACGS likely pathogenic g.11215926G>A g.11105250G>A R94H; FH Fukuoka - LDLR_000052 predicted retained in ER; Functional analysis reveals retention in ER. PubMed: Chiou 2010 - rs201102461 Germline - 1/102 FH patients. Variant not present in Normal Non FH patients in this study. 0.0001838 ExAC, May 2015 - - - Sarah Leigh
Legend   How to query